• OPEN AN ACCOUNT
Indian Indices
Sensex
78,499.17 -455.59
( -0.58%)
Global Indices
Nasdaq
54,056.75 150.65
(0.28%)
Dow Jones
7,778.11 47.15
(0.61%)
Hang Seng
65,597.55 -85.71
(-0.13%)
Nikkei 225
10,909.12 41.23
(0.38%)
Forex
USD-INR
95.20 0.13
(0.14%)
EUR-INR
109.83 0.08
(0.08%)
GBP-INR
128.13 0.14
(0.11%)
JPY-INR
0.60 0.00
(-0.12%)

EQUITY - MARKET SCREENER

BIL Vyapar Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
500059
INE071A01013
-59.3932238
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BILVYAPAR
0
13.02
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Rossari Biotech consolidated net profit rises 33.48% in the March 2026 quarter
Apr 28,2026
Net profit of Rossari Biotech rose 33.48% to Rs 45.97 crore in the quarter ended March 2026 as against Rs 34.44 crore during the previous quarter ended March 2025. Sales rose 18.17% to Rs 684.86 crore in the quarter ended March 2026 as against Rs 579.56 crore during the previous quarter ended March 2025.

For the full year,net profit rose 9.41% to Rs 149.21 crore in the year ended March 2026 as against Rs 136.38 crore during the previous year ended March 2025. Sales rose 15.19% to Rs 2396.37 crore in the year ended March 2026 as against Rs 2080.29 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales684.86579.56 18 2396.372080.29 15
OPM %11.2811.99 -11.9312.74 -
PBDT87.7765.93 33 281.64252.26 12
PBT64.2447.71 35 202.52185.19 9
NP45.9734.44 33 149.21136.38 9